Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex
GlaxoSmithKline (United States)
InstitutionResearch output, impact & collaborations
GlaxoSmithKline (United States) is a research organisation in Philadelphia, US. OpenAlex records 15,015 works and 2,994,258 citations for it. 3,890 researchers list it as their most recent affiliation.
15,015
Works
2,994,258
Citations
3,890
Researchers
44.5
Avg h-index
How has GlaxoSmithKline (United States)'s publication output changed over time?
ScholarIQpublication output · 1999–2020
Output grew0% over the shown period — from 1 works in 1999 to 1 in 2020.
1
1
1
1
1
1
2
1
2
1
1999200120042009201120122016201720192020
Who are the most-cited researchers behind GlaxoSmithKline (United States)?
ScholarIQtop researchers by citations
What are the most-cited papers on GlaxoSmithKline (United States)?
ScholarIQmost cited works
A More Accurate Method To Estimate Glomerular Filtration Rate from Serum Creatinine: A New Prediction Equation
Andrew S. Levey, Juan Bosch, Julia B. Lewis, Tom Greene, Nancy Rogers, David A. Roth, for the Modification of Diet in Renal Disease Study Group*
Annals of Internal Medicine. 199915,156 Citations
Ipilimumab plus Dacarbazine for Previously Untreated Metastatic Melanoma
Caroline Robert, L. Thomas, Igor Bondarenko, Steven O’Day, Jeffrey S. Weber, Claus Garbe, Célèste Lebbé, Jean‐François Baurain, Alessandro Testori, Jean‐Jacques Grob, Neville Davidson, Jon Richards, Michele Maio, Axel Hauschild, Wilson H. Miller, Pere Gascón, Michal Lotem, Kaan Harmankaya, Ramy Ibrahim, Stephen Francis, Tai‐Tsang Chen, Rachel Humphrey, Axel Hoos, Jedd D. Wolchok
New England Journal of Medicine. 20114,477 CitationsOPEN ACCESS
Two-Year, Randomized, Controlled Trial of Belimumab in Lupus Nephritis
Richard Furie, Brad H. Rovin, Frédéric Houssiau, Ana Malvar, Y K Onno Teng, Gabriel Contreras, Zahir Amoura, Xueqing Yu, Chi-Chiu Mok, Mittermayer B. Santiago, Amit Saxena, Yulia Green, Beulah Ji, C. Kleoudis, Susan W. Burriss, Carly Barnett, David A. Roth
New England Journal of Medicine. 20201,005 CitationsOPEN ACCESS
Sequential Therapies for Proliferative Lupus Nephritis
Gabriel Contreras, Victoriano Pardo, Baudouin Leclercq, Oliver Lenz, Elaine Tozman, Patricia O'Nan, David A. Roth
New England Journal of Medicine. 2004820 Citations
Belantamab mafodotin for relapsed or refractory multiple myeloma (DREAMM-2): a two-arm, randomised, open-label, phase 2 study
Sagar Lonial, Hans C. Lee, Ashraf Badros, Suzanne Trudel, Ajay K. Nooka, Ajai Chari, Al‐Ola Abdallah, Natalie S. Callander, Nikoletta Lendvai, Douglas W. Sborov, Attaya Suvannasankha, Katja Weisel, Lionel Karlin, Edward N. Libby, Bertrand Arnulf, Thierry Façon, Cyrille Hulin, K. Martin Kortüm, Paula Rodríguez‐Otero, Saad Z. Usmani, Parameswaran Hari, Rachid Baz, Hang Quach, Philippe Moreau, Peter M. Voorhees, Ira Gupta, Axel Hoos, Eric Zhi, January Baron, Trisha Piontek, Eric Lewis, Roxanne C. Jewell, Elisha J. Dettman, Rakesh Popat, Simona Degli Esposti, Joanna Opalinska, Paul G. Richardson, Adam D. Cohen
The Lancet Oncology. 2019806 Citations
How much of the research on GlaxoSmithKline (United States) is open access?
ScholarIQopen access share
67%OPEN ACCESS
Gold
0%
Green
17%
Hybrid
17%
Bronze
33%
Closed
33%